Logo image of PRLB

PROTO LABS INC (PRLB) Stock Fundamental Analysis

NYSE:PRLB - New York Stock Exchange, Inc. - US7437131094 - Common Stock - Currency: USD

40.56  -1.48 (-3.52%)

After market: 40.56 0 (0%)

Fundamental Rating

4

PRLB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 129 industry peers in the Machinery industry. No worries on liquidiy or solvency for PRLB as it has an excellent financial health rating, but there are worries on the profitability. PRLB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

PRLB had positive earnings in the past year.
PRLB had a positive operating cash flow in the past year.
Of the past 5 years PRLB 4 years were profitable.
Each year in the past 5 years PRLB had a positive operating cash flow.
PRLB Yearly Net Income VS EBIT VS OCF VS FCFPRLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

The Return On Assets of PRLB (2.23%) is comparable to the rest of the industry.
PRLB has a worse Return On Equity (2.48%) than 62.40% of its industry peers.
With a Return On Invested Capital value of 2.38%, PRLB is not doing good in the industry: 70.40% of the companies in the same industry are doing better.
PRLB had an Average Return On Invested Capital over the past 3 years of 2.43%. This is significantly below the industry average of 11.00%.
Industry RankSector Rank
ROA 2.23%
ROE 2.48%
ROIC 2.38%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
PRLB Yearly ROA, ROE, ROICPRLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

PRLB has a Profit Margin (3.31%) which is comparable to the rest of the industry.
PRLB's Profit Margin has declined in the last couple of years.
The Operating Margin of PRLB (5.09%) is worse than 61.60% of its industry peers.
PRLB's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 44.56%, PRLB belongs to the best of the industry, outperforming 84.00% of the companies in the same industry.
In the last couple of years the Gross Margin of PRLB has declined.
Industry RankSector Rank
OM 5.09%
PM (TTM) 3.31%
GM 44.56%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
PRLB Yearly Profit, Operating, Gross MarginsPRLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRLB is destroying value.
The number of shares outstanding for PRLB has been reduced compared to 1 year ago.
PRLB has less shares outstanding than it did 5 years ago.
PRLB has a better debt/assets ratio than last year.
PRLB Yearly Shares OutstandingPRLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRLB Yearly Total Debt VS Total AssetsPRLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

The Debt to FCF ratio of PRLB is 0.01, which is an excellent value as it means it would take PRLB, only 0.01 years of fcf income to pay off all of its debts.
PRLB has a Debt to FCF ratio of 0.01. This is amongst the best in the industry. PRLB outperforms 92.80% of its industry peers.
PRLB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
PRLB has a better Debt to Equity ratio (0.00) than 85.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z N/A
ROIC/WACC0.22
WACC10.6%
PRLB Yearly LT Debt VS Equity VS FCFPRLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 3.66 indicates that PRLB has no problem at all paying its short term obligations.
The Current ratio of PRLB (3.66) is better than 83.20% of its industry peers.
PRLB has a Quick Ratio of 3.43. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
PRLB has a better Quick ratio (3.43) than 91.20% of its industry peers.
Industry RankSector Rank
Current Ratio 3.66
Quick Ratio 3.43
PRLB Yearly Current Assets VS Current LiabilitesPRLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

PRLB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.87%.
The earnings per share for PRLB have been decreasing by -10.19% on average. This is quite bad
The Revenue has decreased by -0.61% in the past year.
Measured over the past years, PRLB shows a small growth in Revenue. The Revenue has been growing by 1.78% on average per year.
EPS 1Y (TTM)1.87%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%-17.39%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%-2.64%

3.2 Future

PRLB is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.41% yearly.
The Revenue is expected to grow by 4.96% on average over the next years.
EPS Next Y-13.17%
EPS Next 2Y-0.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.84%
Revenue Next 2Y4.96%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PRLB Yearly Revenue VS EstimatesPRLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PRLB Yearly EPS VS EstimatesPRLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.88, PRLB is valued on the expensive side.
PRLB's Price/Earnings is on the same level as the industry average.
PRLB's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.63.
A Price/Forward Earnings ratio of 28.66 indicates a quite expensive valuation of PRLB.
62.40% of the companies in the same industry are cheaper than PRLB, based on the Price/Forward Earnings ratio.
PRLB is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.88
Fwd PE 28.66
PRLB Price Earnings VS Forward Price EarningsPRLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PRLB is on the same level as its industry peers.
85.60% of the companies in the same industry are more expensive than PRLB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.48
EV/EBITDA 14.91
PRLB Per share dataPRLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.41%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PRLB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PROTO LABS INC

NYSE:PRLB (2/21/2025, 8:04:00 PM)

After market: 40.56 0 (0%)

40.56

-1.48 (-3.52%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-07 2025-02-07/bmo
Earnings (Next)05-01 2025-05-01/bmo
Inst Owners91.01%
Inst Owner Change-1.51%
Ins Owners0.91%
Ins Owner Change0.14%
Market Cap994.13M
Analysts76.36
Price Target45.22 (11.49%)
Short Float %2.45%
Short Ratio2.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.89%
Min EPS beat(2)16.42%
Max EPS beat(2)43.37%
EPS beat(4)4
Avg EPS beat(4)23.24%
Min EPS beat(4)7.67%
Max EPS beat(4)43.37%
EPS beat(8)8
Avg EPS beat(8)30.53%
EPS beat(12)11
Avg EPS beat(12)25.76%
EPS beat(16)12
Avg EPS beat(16)20.02%
Revenue beat(2)1
Avg Revenue beat(2)0.42%
Min Revenue beat(2)-0.63%
Max Revenue beat(2)1.46%
Revenue beat(4)2
Avg Revenue beat(4)-0.26%
Min Revenue beat(4)-2.44%
Max Revenue beat(4)1.46%
Revenue beat(8)4
Avg Revenue beat(8)0.63%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)7
Avg Revenue beat(16)-0.04%
PT rev (1m)0%
PT rev (3m)5.22%
EPS NQ rev (1m)-12.2%
EPS NQ rev (3m)-26.95%
EPS NY rev (1m)-7.5%
EPS NY rev (3m)-5.61%
Revenue NQ rev (1m)-0.65%
Revenue NQ rev (3m)-6.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 24.88
Fwd PE 28.66
P/S 1.98
P/FCF 14.48
P/OCF 12.77
P/B 1.48
P/tB 2.65
EV/EBITDA 14.91
EPS(TTM)1.63
EY4.02%
EPS(NY)1.42
Fwd EY3.49%
FCF(TTM)2.8
FCFY6.91%
OCF(TTM)3.18
OCFY7.83%
SpS20.44
BVpS27.34
TBVpS15.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.23%
ROE 2.48%
ROCE 3.69%
ROIC 2.38%
ROICexc 2.8%
ROICexgc 5.63%
OM 5.09%
PM (TTM) 3.31%
GM 44.56%
FCFM 13.71%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
ROICexc(3y)2.8%
ROICexc(5y)3.78%
ROICexgc(3y)5.45%
ROICexgc(5y)6.71%
ROCE(3y)3.77%
ROCE(5y)4.91%
ROICexcg growth 3Y-8.13%
ROICexcg growth 5Y-18.97%
ROICexc growth 3Y-4.98%
ROICexc growth 5Y-24.03%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
F-Score7
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 25.61%
Cap/Sales 1.83%
Interest Coverage 250
Cash Conversion 126.96%
Profit Quality 413.79%
Current Ratio 3.66
Quick Ratio 3.43
Altman-Z N/A
F-Score7
WACC10.6%
ROIC/WACC0.22
Cap/Depr(3y)51.87%
Cap/Depr(5y)76.84%
Cap/Sales(3y)3.95%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.87%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%-17.39%
EPS Next Y-13.17%
EPS Next 2Y-0.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%-2.64%
Revenue Next Year2.84%
Revenue Next 2Y4.96%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-9.98%
EBIT growth 3Y-14.15%
EBIT growth 5Y-20.42%
EBIT Next Year60.63%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.04%
FCF growth 3Y48.42%
FCF growth 5Y4.96%
OCF growth 1Y6.22%
OCF growth 3Y12.13%
OCF growth 5Y-7.69%